- alle zwei WochenErscheinungsrhythmus
- 1 h 06typische Länge
- vor 6 Tagenletzte Folge
Folgenzu den neuesten
Episode 21: Scion Life Sciences' Aaron Kantoff
Aaron Kantoff describes the road on the public markets side that eventually led him to venture, and recalls successful investments he helped lead at firms like Apple Tree Partners and Medicxi, such as Stoke Therapeutics, Akero Therapeutics,
Episode 20: Breakout Ventures' Lindy Fishburne
Lindy Fishburne describes her educational background and career, and transitioning from the philanthropic Breakout Labs within the Thiel Foundation to Breakout Ventures, a traditional venture firm that has a diverse set of limited partners.
Episode 19: Longwood Fund's Christoph Westphal
Dr. Westphal describes his upbringing and early career at McKinsey and Polaris, founding or co-founding companies like Momenta, Alnylam, Sirtris, Acceleron, and VeraStem, and creating the Longwood Fund. He shares his thoughts on venture inv
Episode 18: Playground Global's Jory Bell
Jory Bell shares the details of his expansive educational background and early career, which included being a product designer at Apple during the return of Steve Jobs. He describes Playground's engineering and tech angle to investing in li
Episode 17: Norwest Venture Partners' Tiba Aynechi
Tiba Aynechi describes her career path, which has been spent entirely in the Bay Area since she earned her PhD from UCSF in the early 2000's. She describes the value of BD experience she earned while working on licensing deals early in her
Episode 16: RA Capital's Josh Resnick
Josh Resnick describes his career path, which includes working on the venture side of both private funds and pharma (Merck). He explains the different investment strategies of RA Capital, and talks about how the firm's Raven company buildin
Episode 15: Mission BioCapital's Steve Tregay
Steve Tregay describes his career path, including how early roles at Array BioPharma and Novartis led him to found Forma Therapeutics. He describes the founding and growth of LabCentral, for which he is still the chairman today, and how get
Episode 14: Aditum Bio's Joe Jimenez
Joe Jimenez describes the career path in consumer products that led him to pharma, his time running Novartis, and the idea to co-found Aditum Bio with his partner Mark Fishman. He explains Aditum's investment philosophy, and why they like f
Episode 13: Civilization Ventures' Shahram Seyedin-Noor
Shahram describes his upbringing as a refugee from Iran, his early career in law and banking, and how his initial experience in the tech industry has benefitted his eye towards life sciences. He recalls founding Civilization Ventures with a
Episode 12: Flagship Pioneering's Avak Kahvejian
A General Partner at Flagship Pioneering, Avak describes his upbringing and studies in the Middle East and Montreal, Canada, working in industry at Helicos, and co-founding companies at Flagship since 2011. He discusses Flagship's unique pl
Episode 11: Pillar VC's Tony Kulesa
A Partner at Pillar VC, Tony describes his start at MIT, founding the MIT BioMakerspace, his work at Petri, being an early supporter of Nucleate, and his philosophy of not being overly influenced by what is in vogue today.
Episode 10: Curie.Bio's Alexis Borisy
The Co-Founder and Operating Chairman of Curie.Bio, and serial entrepreneur, shares experiences from his early life, CombinatoRx, Foundation Medicine, Third Rock, EQRx and more.
Episode 9: Alloy Therapeutics & 82VS's Errik Anderson
He describes his career path and learnings from the tech industry, co-founding Adimab, the work that Alloy and 82VS do to support and invest in scientist-entrepreneurs, and why he believes smaller organizations are best suited for discovery
Episode 8: Canaan Partners' Julie Grant
A general partner the firm, she describes her career path, including time spent at Goldman Sachs and Genentech, before landing at Canaan over a decade ago. She discusses the firm's investment approach to healthcare, and boldly moving into n
Episode 7: MPM BioImpact's Ansbert Gadicke
MPM's founder and managing partner discusses the firm's 30+ years of investing in life sciences, including the philosophy of placing entrepreneur partners at companies from the start, and teaming up with research institutions and investment
Episode 6: Omega Funds' Otello Stampacchia
He describes his career path, including time in the lab and doing quant work at Goldman Sachs. Plus, what he has learned about VC investing and biotech over time, and how Omega Funds is able to successfully invest in various stages and roun
Episode 5: KdT Ventures' Founder and Managing Partner Cain McClary
He describes this path to venture investing from his start in science at the NIH to becoming a pathologist, and eventually raising a modest first fund and building off of its success. Plus, his investment philosophy and investing in science
Episode 4: Enavate Sciences’ Sara Nayeem
Sara Nayeem describes her career path and how different firms she has worked for have had different approaches to investing. She introduces us to Enavate Sciences, and shares her thoughts on investing in various areas such as rare diseases
Episode 3: Time BioVentures' D.A. Wallach
D.A. Wallach describes how he went from music to healthcare/biotech investing, and the similarities he sees between the two industries. Plus, the firm's investment philosophy and how he partnered with Tim Wright to create the firm.
Episode 2: Westlake BioPartners’ Beth Seidenberg
Beth Seidenberg tells the story of how her career went from physician, to product development in industry, to investor. She describes the qualities she looks for in an entrepreneur, and discusses the Los Angeles core of Westlake BioPartners
Episode 1: Venrock's Bryan Roberts
Bryan Roberts discusses Venrock's history, moving from NYC to the Bay Area, his investment philosophy, portfolio construction and concentration, the types of entrepreneurs he looks for, what qualities make for a good early stage investor, t
